Open Access. Powered by Scholars. Published by Universities.®
- Discipline
- Keyword
-
- Access to medicines (1)
- Article 39 (1)
- Competitiveness (1)
- Compulsory licensing (1)
- Data exclusivity (1)
-
- Developing countries (1)
- Discriminate (1)
- Domestic (1)
- Economy (1)
- Exports (1)
- Generic drugs (1)
- ITC (1)
- Imports (1)
- India (1)
- Industrial policies (1)
- Intellectual property (1)
- Investment (1)
- Patent (1)
- Patent position (1)
- TRIPS (1)
- TRIPS Agreement (1)
- Tariff (1)
- Unfair competition (1)
- United States (1)
- United States International Trade Commission (1)
- United States Trade Representative (1)
- WIPO (1)
- World Trade Organization (1)
Articles 1 - 3 of 3
Full-Text Articles in Intellectual Property Law
The Significance Of The Data Exclusivity And Its Impact On Generic Drugs, Srividhya Ragavan
The Significance Of The Data Exclusivity And Its Impact On Generic Drugs, Srividhya Ragavan
Srividhya Ragavan
The following is a law review interview with Professor Srividhya Ragavan on the issues in interpretation of data exclusivity provisions under the TRIPS Agreement, and the impact of data exclusivity on generic drugs.
Justifying India's Patent Position To The United States International Trade Commission And Office Of The United States Trade Representative, Srividhya Ragavan, Sean Flynn, Brook Baker
Justifying India's Patent Position To The United States International Trade Commission And Office Of The United States Trade Representative, Srividhya Ragavan, Sean Flynn, Brook Baker
Srividhya Ragavan
The paper below largely is an extract of the testimonial filed by the authors to the Secretary of the ITC in response to the Notice on the Federal Register dated August 29, 2013 titled Trade, Investment, and Industrial Policies in India: Effects on the U.S. Economy. Where required, the paper also draws from the written submissions that the authors made to the United States Trade Representative’s (hereinafter, USTR) office on the related question of whether India deny adequate and effective protection of intellectual property rights or deny fair and equitable market access to U.S. persons who rely on intellectual property …
Drugs, Drugs Everywhere But Just Not For The Poor, Srividhya Ragavan
Drugs, Drugs Everywhere But Just Not For The Poor, Srividhya Ragavan
Srividhya Ragavan
The objective for this article is to understand the legitimacy and limitations of US involvement in another country’s sovereign actions taken expressly in the public interest, or to protect public health, such as the compulsory licensing of pharmaceuticals.